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Abstract An inwardly rectifying K
+ current is present in
atrial cardiac myocytes that is activated by acetylcholine
(IKACh). Physiologically, activation of the current in the SA
node is important in slowing the heart rate with increased
parasympathetic tone. It is a paradigm for the direct
regulation of signaling effectors by the Gβγ G-protein
subunit. Many questions have been addressed in heterolo-
gous expression systems with less focus on the behaviour in
native myocytes partly because of the technical difficulties
in undertaking comparable studies in native cells. In this
study, we characterise a potassium current in the atrial-
derived cell line HL-1. Using an electrophysiological
approach, we compare the characteristics of the potassium
current with those in native atrial cells and in a HEK cell
line expressing the cloned Kir3.1/3.4 channel. The potas-
sium current recorded in HL-1 is inwardly rectifying and
activated by the muscarinic agonist carbachol. Carbachol-
activated currents were inhibited by pertussis toxin and
tertiapin-Q. The basal current was time-dependently in-
creased when GTP was substituted in the patch-clamp
pipette by the non-hydrolysable analogue GTPγS. We
compared the kinetics of current modulation in HL-1 with
those of freshly isolated atrial mouse cardiomyocytes. The
current activation and deactivation kinetics in HL-1 cells
are comparable to those measured in atrial cardiomyocytes.
Using immunofluorescence, we found GIRK4 at the
membrane in HL-1 cells. Real-time RT-PCR confirms the
presence of mRNA for the main G-protein subunits, as well
as for M2 muscarinic and A1 adenosine receptors. The data
suggest HL-1 cells are a good model to study IKAch.
Keywords HL-1 cells.GIRK.Kir 3.1/3.4.
Atrial mouse cardiomyocytes.Muscarinic M2 receptor.
Potassium channels.HEK cells
Introduction
Control of heart rate is a complex process that integrates the
function of multiple G-protein-coupled receptors and ion
channels. Acetylcholine released from the vagus nerve
efferents activates muscarinic receptors on SA nodal cells,
initiating a sequence of signaling events. A decrease in
heart rate is caused by inhibition of adenylate cyclase via
inhibitory heterotrimeric G-proteins and inhibition of If
current activity and by the activation of an inwardly
rectifying K
+ current [1–4]. Inwardly rectifying potassium
channels gated by G-proteins (GIRK) are also present atrial
myocytes [5]. The molecular counterparts of these channels
have been identified as members of the Kir3.x family of
inwardly rectifying K
+ channels and heterotetramers of
Kir3.1/3.4 (GIRK1/4) are predominant in the heart [6].
GIRK channels are activated by direct interaction with βγ
subunits released from inhibitory heterotrimeric G-proteins
upon agonist stimulation of appropriate G-protein-coupled
receptors such as the M2 muscarinic and A1 adenosine
receptors in the heart. In many ways, this pathway is an
exemplar of how G-protein βγ subunits directly regulate a
signaling effector [7]. Furthermore, there is emerging
evidence that receptor, inhibitory G-protein, regulators of
G-protein signaling and channel may be scaffolded together
[8–13]. This hypothesis is largely based on the over-
expression of components in heterologous expression sys-
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such models are when considering signaling in native
systems. To some extent, this can be realised by isolating
single nodal and atrial myocytes from genetically modified
mice or by establishing short-term culture and subsequent
viral transfection of acutely isolated cells. However, both
these approaches are time-consuming and technically de-
manding [4, 5, 14–16]. It would be valuable to have a
system that reproduced native signaling whilst allowing
routine molecular manipulation such as transfection of
cDNAs and siRNA duplexes with lipid-based methods.
The HL-1 cell line was derived from AT-1 cardiac
myocytes, which are atrial cardiac muscle cells obtained from
transgenicmiceinwhichexpressionoftheSV40largeantigen
was controlled by the atrial natriuretic factor promoter [17].
HL-1 cells are currently the only cardiomyocyte cell line that
divides, spontaneously contracts while maintaining a differ-
entiated cardiac phenotype. The HL-1 cell line has been
shown to express functional channels characteristic of
cardiac cells: the L- and T-type Ca2+ channels [18], as well
as the hyperpolarisation-activated non-selective cation chan-
nel If [19]. HL-1 cells also beat spontaneously in culture
[20]. Inthiswork,weseektoestablishiftheHL-1celllineisa
potential genetically tractable model for studying the musca-
rinic regulation of the cardiac G-protein gated inwardly
rectifying K
+channel.
Materials and methods
Cell culture
The HL-1 cell line was a gift from Prof. William C.
Claycomb (Louisiana State University, Baton Rouge, LA)
and was maintained using his recommended protocols. HL-1
cells were cultured under 5% C02 atmosphere in Claycomb
medium supplemented with 10% foetal bovine serum,
0.2 mM L-glutamine, 0.1 mM norepinephrine, 100 units/ml
penicillin and 100 µg/ml streptomycin (all from Sigma).
These conditions, including the addition of norepinephrine,
were necessary to ensure cell division and maintenance of
the cell phenotype. The medium was replaced every day.
Cells were grown onto T75 culture flasks pre-coated
overnight with 0.03% fibronectine/0.02% gelatine solution.
For electrophysiology and imaging experiments, cells were
grown on uncoated 13-mm glass coverslips (BDH).
Atrial mouse cardiomyocyte isolation was achieved
using a method adapted from a previously published
approach [21]. Atrial cells were isolated from adult C57
black mice. All experiments were conducted according to
the British Home Office animal welfare guidelines.
At the time of study, mice (equal sex distribution) were
12–14 weeks of age, weighing 20–25 g. Animals were
injected 20 min prior to isolation with a bolus of heparin
sodium 250 IU. Hearts were rapidly excised from anaesthe-
tized (ketamine 0.01 ml/mg, xylazine 10 mg/ml, atropine
0.06 mg/ml) animals and attached (by the aorta) to a
Langendorff perfusion apparatus. Isolated hearts were retro-
gradely perfused for 10 min with a buffer containing (in
millimolar) 113 NaCl, 4.7 KCl, 0.6 KH2PO4, 0.6 Na2HPO4,
1.2 MgSO4.7H2O, 12 NaHCO3, 10 KHCO3, 30 taurine, 10
HEPES, 11 glucose and 10 2,3-butanedione monoxide,
followed by a solution containing 1 mg/ml collagenase type
Vand 1 mg/ml Protease XIV (both from Sigma) and 50 μM
calcium. The temperature of the heart and the perfusate were
maintained at 35–37°C and saturated with 95% O2–5% CO2.
The enzymatic solution was filtered (5 μm) and re-circulated
through the heart until the atria were digested (20–35 min), as
judged by eye. After perfusion, the atria and appendages were
removed, minced and incubated in a fresh solution containing
enzymes for an additional 10 min, under shaking condition at
35–37°C and saturated with 95% O2–5% CO2. The tissue
pieces were then transferred to 10 ml of fresh (enzyme-free)
solution supplemented with 5 mg/ml bovine serum albumin
(BSA,Sigma)and150μMCaCl2and,gentlytrituratedwitha
fire-polished Pasteur pipette for 5–10 min. The resulting
suspension was then centrifuged (600 rpm, 5 min); the
supernatant was discarded, and the cells were resuspended in
fresh BSA-containing solution. This step was repeated twice
to completely wash out the enzyme and remove unwanted
cellular fragments. Isolated atrial myocytes were resuspended
in 2 ml fresh BSA-containing solution, plated on laminin-
coated glass coverslips onto 13-mm cell culture coverslips
(BDH) and placed in 95% O2–5% CO2 in an incubator at
37°C for 20 min. After 30–45 min, cells were gently
resuspended into 2 ml MEM containing foetal bovine serum
10% and penicillin/streptomycin 1%. Cells were used for
electrophysiology 1 h after plating for the day.
Cell culture methods and the generation of stable cell
lines were as described [22]. HEK293 cells (human
embryonic kidney cell line) expressing M2 receptor and
GIRK1/4 channel were maintained in minimum essential
medium supplemented with 10% foetal calf serum and
727 μg of G418 and 364 μg/ml Zeocin (Invitrogen), at
37°C in humidified 95% O2–5% CO2.
Electrophysiology
Whole-cell patch-clamp current recordings were performed
with an Axopatch 200B amplifier (Axon Instruments) using
fire-polished pipettes with a resistance of 3–4M Ω, pulled
from filamented borosilicated glass capillaries (Harvard
Apparatus, 1.5 mm OD×1.17 mm ID). Data were acquired
and analysed by using a Digidata 1322A interface (Axon
Instruments) and pCLAMP software (version 10, Axon
Instruments). Cells were clamped at −50 mV and bathed in
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KCl 20, CaCl2 2, MgCl2 1, HEPES 10, pH 7.4, while the
intracellularsolution was(millimolar):Kgluconate 110,KCl
20, NaCl 10, MgCl2 1, MgATP 2, EGTA 2 GTP 0.3, pH 7.4.
The text and figure legends indicate where modifications
were made to this. Drugs were applied by a gravity driven
perfusion system. Membrane currents were elicited with a
series of 420 ms depolarisation pulses to +60 in 20 mV
decrements from a holding potential of −50 mVapplied at a
frequency of 10 Hz. Current densities were measured at a
holding potential of –120 mV, unless otherwise stated.
For the evaluation of current kinetics, a fast perfusion
system was used to apply drugs (Rapid Solution Changer,
RSC-160, Bio-Logic France). Cells were clamped at
−60 mV, the extracellular solution was (millimolar): NaCl
80, KCl 60, CaCl2 2, MgCl2 1, HEPES 10, NaH2PO4
0.33, glucose 10, while the intracellular solution has the
same composition as the one mentioned above. After
agonist application, current activated with a delay “lag”
followed by a rapid rise to peak amplitude “time to peak”.
After removal of the agonist, the current decays back to
baseline. Current activation and deactivation were fitted by
a single exponential function Aexp(−t/τ)+C (where A is
the current amplitude at the start of the fit, t is time, τ is the
activation or the deactivation time constant, and C is the
steady-state asymptote). For each cell, we assessed whether
there were any flow artefacts resulting from the pressure of
drug application. We did this by applying bath solution
from one of the sewer pipes at the beginning of the
recordings. Furthermore, to control for variations in
positioning of the sewer-pipe system relative to the cell,
we calibrated the system by using the kinetics of channel
block by 1 mM barium. Block of the current occurred with
an initial delay “lag” before reaching equilibrium; it was
assumed that this lag reflected the intrinsic delivery time to
the cell. The lag time for barium was 194±13 ms (n=16).
Immunofluorescence
Cells were cultured in 13-mm glass-bottom Petri dishes
(Mattek), for 48 h. Cells were washed twice with phosphate
buffered saline (PBS) containing 0.1 mM CaCl2 and 1 mM
MgCl2. Cells were fixed for 20 min, at 4°C, with PBS
solution containing 4% paraformaldehyde, and then washed
twice with PBS. Then the cells were permeabilised with
PBS containing 0.2% Triton and 5% goat serum (Gibco).
After 20 min, the solution was removed and replaced by the
primary antibody diluted in the above buffer. GIRK4 (APC-
027, Alomone Laboratories) and M2 receptor (AMR-002,
AlomoneLaboratories)antibodieswereusedatafinaldilution
of 1/500. Incubation was carried for 90 min, followed by
three washes with PBS. Then, the cells were incubated for
60 min with Alexa 488 (goat anti-rabbit A1108, Molecular
Probes) in the dark. During incubation with primary and
secondary antibodies, 5% goat serum (Gibco) was used to
minimise non-specific staining. Appropriate controls (not
shown) were undertaken with non-transfected HEK293 cells
and incubation of HL-1 and M2 GIRK1/4 cell lines with
secondary antibody alone. Cells were then finally washed
three times with PBS and imaged with a Biorad confocal
microscope. The cells were excited using a 488-nm laser line,
and emission was measured using a LP500 filter.
Real-time quantitative RT-PCR
Real-time RT-PCR was performed using Taqman Gene
ExpressionAssays(AppliedBiosystems)usingeitherinvento-
ried,made-to-orderorcustom-made assays.Protocolfollowed
wasbasedontheinformationprovidedbythesuppliers,which
is available on their website http://www3.appliedbiosystems.
com/cms/groups/mcb_support/documents/generaldocuments/
cms_041280.pdf).
Briefly, hearts were removed from the C57 black wild-
type mice, washed with cold PBS and immediately placed
in liquid nitrogen. Atrial tissue was ground under liquid
nitrogen with a pestle and mortar. We then proceeded with
the extraction of RNA using RNeasy kit (cat no. 74104
Qiagen). Similarly, HL-1 cells were harvested from the
culture, and RNA was extracted using RNeasy kit (cat no.
74104 Qiagen). cDNA was synthesised using high-capacity
cDNA reverse transcription Kit (4368814 Applied Bio-
systems) from both native cells and HL-1 cell lines. cDNA
was quantified, and 50 ng/µl of DNA/20 µl was used for the
subsequent real-time expression assay. All genes were
assayed in triplicates, and glyceraldehyde-3-phophate dehy-
drogenase (GAPDH) was used as the house-keeping gene.
Table 1 Kinetics of current activation, desensitisation and deactivation
Cells Cell capacitance
(pF)
I basal
pA/pF
I agonist
pA/pF
Lag+TTP
sec
τac
seconds
Percent
desensitisation, %
τdeact
seconds
HL-1 cell line, n=15 16.4±1 −30±11.6 −81.6±21 3.6±0.5 1.44±0.31 8.4±1.5 6.2±0.5
Mouse atria, n=20 31.5±2.2 −71±6.1
a −64±8.5 4.3±0.7 0.63±12 3.2±0.9
a 4±1
M2 GIRK1/4 cell line, n=11 22.2±1.8 −44±4.3 −125±49 7.4±0.9 1.61±0.21 6±1.3 8.5±0.9
ap<0.05 compared with HL-1 cell line. Data are shown as mean±SEM
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Data are presented as mean ± SEM unless otherwise
indicated. A Student's t test was used for statistical
comparison and *p<0.05 and **p<0.01.
Results
Carbachol-induced potassium current in the HL-1 cell line
Using the whole-cell configuration of the patch-clamp
technique, we studied receptor-mediated GIRK currents in
HL-1 cells and compared this with a HEK293 stable line
expressing the Kir3.1\3.4 channel complex along with the
M2 receptor as a positive control (denoted M2 GIRK1/4
cell line). In HL-1 cells and the M2 GIRK1/4 cell line, there
was a basal inwardly rectifying current that reversed at
approximately the equilibrium potential for K
+ in these
solutions (Table 1 and Figs. 1 and 2). The application of the
non-specific muscarinic receptor agonist carbachol (10 μM)
further increased the inward currents (Table 1). The current
elicited by carbachol was blocked by the GIRK channel
inhibitor tertiapin-Q (100 mM, Figs. 1, 2 and 3a, p<0.01).
Pertussis toxin catalyses the ADP ribosylation of the Gi/o α
subunit at a cysteine residue four amino acids from the C-
terminal end of the protein, and the modified G-proteins are
unable to participate in signaling. Treatment of HL-1 cells
with pertussis toxin (100 ng/ml for 16 h overnight) led to an
inhibition of the carbachol-induced current in HL-1 cells
(Fig. 3a, p<0.01).
Fig. 1 K
+ current activated by carbachol in HL-1 cells. Carbachol
activates an inwardly rectifying K
+ current in HL-1 cells. Sample
voltage-clamp recordings and current voltage relationships are shown
Fig. 2 K
+ current activated by carbachol in HEK293 stable cell line.
Carbachol activates an inwardly rectifying K
+ current in a stable
HEK293 cell line expressing the M2 receptor and the GIRK1 and
GIRK4 channel subunits. Sample voltage-clamp recordings and
current voltage relationships are shown
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gated inwardly rectifying K
+ current analogous to IKACh
in HL-1 cells. To further characterise this current, we
looked at the GTP-dependency of the channel activation by
using different concentrations and varying the GTP species
in the intracellular solution in the patch pipette. The results
are shown in Fig. 3b, c. Four sequential applications of
carbachol every minute in the presence of 30 µM GTP in
the pipette solution led to a stable agonist-activated current
on each application of the agonist (Fig. 3b). However, when
GTP was omitted, we observed a progressive decline in the
agonist-induced current. When compared, the currents at
the fourth application of carbachol was significantly (p<
0.05) lower when GTP was omitted from the patch pipette.
Thus, the magnitude of the receptor-activated current is
dependent on GTP. In another set of experiments, we used the
non-hydrolysable GTP analogue, GTPγS (30 µM), in the
intracellular solution (Fig. 3c). The current was recorded
every minute for a 3-min period after break-in, and we
observed a progressive increase of basal inwardly rectifying
currents (p<0.05 compared with the basal current at the
beginning of the recordings). Further application of carba-
chol led to a small increase in the current. We conclude that
the current in the HL-1 cell line can be activated by using the
non-hydrolysable form of GTP, GTPγS.
We have found that one of the more sensitive methods of
measuring changes in signaling “strength” is to quantify the
dynamics of current modulation after the application of a
saturating dose of agonist. Carbachol was applied to cells
using a fast application system for 20 s and then rapidly
removed. We compared the kinetics of current activation,
the degree of rapid desensitisation at the end of agonist
application, and the kinetics of deactivation of the HL-1
cells with those of freshly isolated mouse atrial cardiomyo-
cytes. Currents activated with a lag and then an exponential
rise before reaching a peak amplitude (lag+time to peak or
“TTP”). A single exponential function was used to fit the
latter activation phase (τac). With prolonged agonist
application, current amplitude wanes as the response
desensitises (acute desensitisation), and upon removal of
agonist, it deactivates back to baseline levels. Deactivation
of currents following agonist removal could also be well-
fitted by a single exponential function (τdeact). The kinetics
of activation and deactivation of HL-1 resemble those of
the mouse atrial cells (Fig. 4 and Table 1), the only
significant difference being a smaller percentage of acute
desensitisation of the GIRK current in the mouse atria
compared with the HL-1 cell line and increased basal
currents (p<0.05 both).
Fig. 3 Dependence of K
+ current activation on G-proteins in HL-1
cells. a The bar charts summarise the results obtained. Treatment with
pertussis toxin (100 ng/ml for 16 h) or tertiapin-Q (100 nM) led to
inhibition of the carbachol-activated current (p<0.01 for both). b
Carbachol (10 µM) was applied four times for 1 min, with 1-min
interval between applications, in the presence or absence of 0.3 mM
GTP. Decline of the current elicited by carbachol was obtained only in
the set of experiments where GTP was omitted (p<0.05). c Currents
were recorded for 3 min after break-in before addition of 10 µM
carbachol in the presence of 30 µM intracellular GTPγS. Currents
activated with dialysis of GTPγS into the cell (p<0.05 compared with
current at t=0) and carbachol evoked smaller currents
b
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and M2 in the HL-1 cell line
We used an antibody against the GIRK4 subunit to look at
the presence and distribution of the channel in the HL-1 cell
line. All the cells show staining (Fig. 5). As a positive
control, we stained the M2 GIRK1/4 cell line with the same
GIRK4 antibody. In an analogous manner, the M2 receptor
was also present in the HL-1 cells (Fig. 5). The pattern of
staining for GIRK4 in the HL-1 cells appears to be different
from that in the HEK293 stable line. Thus, we performed
two additional controls. Firstly, in HEK293 cells without
GIRK4 expression, the GIRK4 antibody does not stain the
cells (Fig. 5). Secondly, incubation of the M2 GIRK1/4 cell
line with only the secondary antibody, and not the primary,
does not lead to staining (Fig. 5).
Real-time quantitative RT-PCR
We also examined the expression of G-proteins (Gi\o and Gs),
the M2 muscarinic, A1 adenosine receptor and the GIRK1
and GIRK4 channel subunits at the transcriptional level
using real-time RT-PCR. Data are expressed as ΔCt
compared with the “house-keeping” gene GAPDH (a higher
value reflects lower expression and single cycle difference
reflects a twofold expression difference assuming high-
efficiency PCR). There are two notable features with the
data. The first is that the general pattern of expression is
similar between the two lines. For example, in the inhibitory
family of G-proteins Gi2 and Go α subunits are the most
highly expressed compared with Gi1 and Gi3. The only
exception to this might be the ratio of GIRK1/4 expression.
The second point is that the relative expression compared
with the house-keeping gene of all the proteins is lower in
the HL-1 cells compared with the native atrial cells (Fig. 6).
This is discussed further below.
Discussion
GIRK channels are activated through various seven helical
receptors coupled to inhibitory heterotrimeric G-proteins
(Gi/Go). Receptor activation after agonist binding leads to
GDP release, GTP binding on the Gα subunit, and
dissociation of the heterotrimeric G-protein subunits, Gα-
GTP and Gβγ. The βγ subunits then interact with the
GIRK channel, causing an increase in the open probability
of the channel complex. The classical model for this
Fig. 4 Kinetics of activation of the K
+ current. Representative current
traces recorded from HL-1 cells, native mouse atrial myocytes and the
M2 GIRK1/4 cell line. Cells were clamped at −80 mV and 10 µM
carbachol was applied for 20 s. The mean parameters are summarised
in the Table. Dotted lines indicate zero current
b
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nents and interaction by random collision [23]. However,
this model has been challenged, and the emerging view is
that components of the signaling cascade form a multimeric
complex at the cell membrane. There is published work
showing that inhibitory Gα subunits directly associate with
the channel and control channel gating [9–11, 22, 24] and
that G-protein-coupled receptors and regulators of G-
protein signaling may participate in this multimeric com-
plex [8, 13, 25, 26]. Proteomic studies indicate other
signaling components may be present too [27]. The
development of these models has been heavily dependent
upon the overexpression of signaling components in
heterologous expression systems. There are questions about
whether such schemes are applicable to the signaling
system in native atrial or nodal cardiac myocytes and also
about which specific isoforms of the various proteins are
important. For example, it seems that RGS4 and Gi2 are
critical in nodal cells [15, 28]. However, these experiments
used mice with global genetic deletion of the proteins, and
this is time-consuming, expensive and not always feasible
to undertake. It would be valuable to have a system that
endogenously expressed the signal transduction cascade
and was readily manipulated using standard transfection
Fig. 5 Immunostaining of HL-1
cells. Immunofluorescent
staining of HL-1 cells and the
M2 GIRK1/4 cell line stained
for GIRK4 and the M2 receptor,
respectively. Arrows show
potential membrane localisation.
In the lower panels of the figure,
two controls are shown. In
parental HEK293 cells without
GIRK4 expression, the GIRK4
antibody does not stain the cells.
Incubation of the M2 GIRK1/4
cell line with only the secondary
antibody and not the primary
does not lead to staining
Pflugers Arch - Eur J Physiol (2010) 460:99–108 105techniques. There are also ethical considerations for
reducing the use of animals for such work. The aim of this
work was to investigate whether the HL-1 cell line could
fulfil such a role.
In HL-1 cells, we isolated an inwardly rectifying K
+
current that was activated by a muscarinic agonist and
inhibited by the relatively specific blocker tertiapin-Q [29].
The receptor modulation was inhibited by pertussis toxin
and dependent on the provision of GTP, characteristics of
the G-protein gated Kir3.0 family of channel as opposed to
the constitutively active Kir2.0 group also present in
cardiac cells. We examined whether GIRK4 (Kir3.4) was
present using immunofluorescence, and indeed, it was.
GIRK4 is a characteristic component of the cardiac current
as opposed to the molecular constituents of the current in
central neurones and neuroendocrine cells [6, 30]. In order
to characterise further the GIRK current recorded in the
HL-1 cell line, we looked at the kinetics of activation and
deactivation using a fast perfusion protocol. The kinetics,
current densities and degree of acute desensitisation were
either not significantly different from those in acutely
isolated mouse atrial cells or were only marginally
different. We have found the signaling dynamics to be a
good indicator of the status of the transduction cascade, and
the assay can report perturbations and differences with high
sensitivity [8, 31, 32]. The fact that the kinetics are so
closely matched is good evidence that the pathway is highly
comparable. Immunofluorescence revealed the presence of
GIRK4 in HL-1 cells; however, there was significant
localization in an intracellular pool. The physiological
significance of this is as yet unclear; however, it is
noteworthy that cell signaling can influence the trafficking
of ion channels to and from the plasma membrane [33].
We also investigated the relative expression of G-protein
alpha subunits, the A1 and M2 G-protein-coupled receptors
and GIRK1 and GIRK4 using real-time quantitative RT-
PCR. The rank order of expression was similar in the two
cell types except for GIRK1 and GIRK4 (discussed below).
For example, both Gi2 and Go were the best expressed of
the inhibitory heterotrimeric G-proteins. This is consistent
with our recent in vivo studies in genetically modified mice
[28] in which we saw phenotypes in heart rate regulation in
Gi2 and Go global knockout mice but none in a combined
knockout of Gi1 and Gi3. A second issue is that, relative to
a control gene, the expression of the assayed proteins is
reduced in HL-1 cells. Glyceraldehyde-3-phosphate dehy-
drogenase is a cytoplasmic glycolytic enzyme, whereas the
proteins whose relative transcriptional expression we
assayed are extrinsic or intrinsic membrane proteins. We
have noticed that native atrial myocytes are larger than the
HL-1 cells whose size is quite heterogenous (see Table 1
for cell capacitances). For a cytoplasmic enzyme, concen-
tration will be proportional to the cell radius to the 3rd
power (r3) whilst density in the plasma membrane will be
scaled to r2. Thus, as cell size increases, it might be
expected that all else being equal you might need relatively
more mRNA for a cytoplasmic enzyme than for one that
encodes a membrane protein. Whilst this general issue of
how cells adapt gene expression to changing cell size has
not been studied, to our knowledge, it is clear that failure to
adapt in cardiac hypertrophy may underlie some of the
apparent electrical remodeling [34].
There were some differences between native atrial cells
and the HL-1 cells. Firstly, in native atrial myocytes, there
were increased basal current densities. This could accounted
f o rb ya ni n c r e a s ei nf r e eG βγ due to differences in
endogenous basal signaling or the expression of activators
of G-protein signaling or guanine nucleotide dissociation
inhibitors [35, 36]. Alternatively, there may be higher levels
of expression of the Kir2.0 family of inward rectifiers in the
atrial cells, but the systematic exploration of this possibility
would require extensive further work and is a topic for
future investigation. In general, in atrial cells, there is only
modest relative expression of classical strong inward
rectifiers generated by Kir2.0 compared with the G-
protein-gated channel [37]. A further possibility is that
there may be differences in the preponderance of GIRK4
homomultimers. Our real-time RT-PCR studies revealed
that the expression of GIRK1 and GIRK4 in HL-1 cells was
approximately equivalent, whilst in atrial cells, GIRK4
expression was reduced compared with GIRK1. The
increase in currents upon muscarinic receptor activation
were however similar. Secondly, we found that rapid
desensitisation was less prominent in the atrial cells. In
our studies to date, on acutely isolated mouse (C57 black
mice specifically) atrial cells, we have found this phenom-
Fig. 6 Quantitative real-time RT-PCR. ΔCt values in quantitative real-
time RT-PCR experiments performed as indicated in the methods.
Data are shown as mean ± SD (n=3 for HL-1 cells and n=6 from two
mice)
106 Pflugers Arch - Eur J Physiol (2010) 460:99–108enon to be quite variable—prominent in some cells, but not
present in others. We have previously argued that it reflects
the dynamics of the G-protein cycle [38], and presumably,
there may be some subtle differences between atrial cells
and HL-1 cells and also within atrial cells as a population.
The existence of the IKACh current in HL-1 cells may
have additional uses. There is accumulating evidence that
there is constitutive activity of GIRK currents in atrial
fibrillation [39, 40]. In addition, these currents are largely
expressed in supraventricular tissues, and thus, Kir3.1/3.4
represents a potential drug target for treating atrial
fibrillation [41]. Furthermore, rapid pacing of HL-1 cells
leads to transcriptional remodeling characteristic of atrial
fibrillation [42]. Thus, HL-1 cells might be a useful model
for adaptive electrophysiological changes that occur in
atrial fibrillation. In summary, we show that HL-1 cells
possess a G-protein-gated inwardly rectifying K
+ current
that is analogous in properties and receptor-mediated
regulation to its counterpart in native atrial myocytes.
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